Combination of a macrocyclic inhibitor of HCV, a non-nucleoside and a nucleoside

Details for Australian Patent Application No. 2011239974 (hide)

Owner Janssen Pharmaceuticals, Inc. Medivir AB

Inventors Lin, Tse-I; Lenz, Oliver; Raboisson, Pierre Jean-Marie Bernard

Agent Shelston IP

Pub. Number AU-A-2011239974

PCT Pub. Number WO2011/128378

Priority 10159825.8 13.04.10 EP

Filing date 13 April 2011

Wipo publication date 20 October 2011

International Classifications

A61K 31/427 - not condensed and containing further heterocyclic rings

A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 31/506 - not condensed and containing further heterocyclic rings

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/128378 Priority application(s): WO2011/128378

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011239977-Triazole compounds as KSP inhibitors

2011239966-Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins